As of 2025-05-21, the EV/EBITDA ratio of Metabiomed Co Ltd (059210.KQ) is 11.16. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. 059210.KQ's latest enterprise value is 185,976.80 mil KRW. 059210.KQ's TTM EBITDA according to its financial statements is 16,668.51 mil KRW. Dividing these 2 quantities gives us the above 059210.KQ EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 6.5x - 8.6x | 6.8x |
| Forward P/E multiples | 4.6x - 6.2x | 5.6x |
| Fair Price | 1,937.55 - 4,207.40 | 2,872.47 |
| Upside | -67.6% - -29.6% | -52.0% |
| Date | EV/EBITDA |
| 2025-04-25 | 9.36 |
| 2025-04-24 | 9.43 |
| 2025-04-23 | 9.38 |
| 2025-04-22 | 9.38 |
| 2025-04-21 | 9.48 |
| 2025-04-18 | 9.48 |
| 2025-04-17 | 9.55 |
| 2025-04-16 | 9.54 |
| 2025-04-15 | 9.58 |
| 2025-04-14 | 9.54 |
| 2025-04-11 | 9.40 |
| 2025-04-10 | 9.35 |
| 2025-04-09 | 8.89 |
| 2025-04-08 | 8.91 |
| 2025-04-07 | 9.04 |
| 2025-04-04 | 9.30 |
| 2025-04-03 | 9.04 |
| 2025-04-02 | 8.97 |
| 2025-04-01 | 9.03 |
| 2025-03-31 | 8.84 |
| 2025-03-28 | 8.97 |
| 2025-03-27 | 9.04 |
| 2025-03-26 | 9.02 |
| 2025-03-25 | 9.15 |
| 2025-03-24 | 9.40 |
| 2025-03-21 | 9.10 |
| 2025-03-20 | 8.84 |
| 2025-03-19 | 8.91 |
| 2025-03-18 | 9.07 |
| 2025-03-17 | 8.87 |
| 2025-03-14 | 8.87 |
| 2025-03-13 | 8.72 |
| 2025-03-12 | 8.81 |
| 2025-03-11 | 8.42 |
| 2025-03-10 | 8.51 |
| 2025-03-07 | 8.44 |
| 2025-03-06 | 8.37 |
| 2025-03-05 | 8.42 |
| 2025-03-04 | 8.44 |
| 2025-02-28 | 8.52 |
| 2025-02-27 | 8.67 |
| 2025-02-26 | 8.61 |
| 2025-02-25 | 8.69 |
| 2025-02-24 | 8.67 |
| 2025-02-21 | 8.77 |
| 2025-02-20 | 8.66 |
| 2025-02-19 | 8.84 |
| 2025-02-18 | 8.87 |
| 2025-02-17 | 8.82 |
| 2025-02-14 | 8.51 |